戻る
「早戻しボタン」を押すと検索画面に戻ります。 [閉じる]

コーパス検索結果 (１語後でソート)

通し番号をクリックするとPubMedの該当ページを表示します
1 dy state erythropoiesis in a murine model of chronic anemia.
2 solely related to hemodynamic adaptations to chronic anemia.
3  a common adaptive response in patients with chronic anemia.
4 p that presents as pure red cell aplasia and chronic anemia.
5  may have pathological implications in acute/chronic anemia.
6 s is often dysregulated, leading to acute or chronic anemia.
7          Other Hb levels were categorized as chronic anemia.
8 ry artery disease, chronic lung disease, and chronic anemia.
9 sors and is widely used for the treatment of chronic anemia.
10 sis and offers a new strategy for overcoming chronic anemias.
11                             Symptoms include chronic anemia, acute chest syndrome, stroke, splenic an
12                                              Chronic anemia also leads to background symptomatology s
13  elevated risk of complications arising from chronic anemia and hypoxia, ongoing hemolysis, iron over
14                                              Chronic anemia and iron overload are believed to lie beh
15  major causes ineffective erythropoiesis and chronic anemia and is associated with iron overload due
16 mpounds as therapeutics for the treatment of chronic anemia and ischemia.
17 ; for example, EE individuals exhibit a mild chronic anemia, and HbE/beta-thalassemia individuals sho
18 3 ligase, and an important target in cancer, chronic anemia, and ischemia.
19  for adequate oxygen delivery in the face of chronic anemia) are mediated by non-NO vasodilators (i.e
20 s compensatory erythropoiesis in response to chronic anemia as well.
21 symptomatic until they developed B19-induced chronic anemia at the ages of 8, 14, and 17 years, respe
22 ed with less favorable post-MI outcomes than chronic anemia but did not modify the effects of the ran
23 m acute anemia, analysis of a mouse model of chronic anemia demonstrated that activation of the BMP4-
24               Parvovirus B19 (B19) can cause chronic anemia due to persistent infection in immunocomp
25 reased red cell turnover in SCD and in other chronic anemia (eg, thalassemia) and may contribute to i
26 imilar for participants with either acute or chronic anemia for all outcomes.
27              Patients with heart failure and chronic anemia frequently demonstrate left ventricular (
28        Clinical and hematological profile of chronic anemia in children after orthotopic liver transp
29  because of the cardiovascular adaptation to chronic anemia in non-cardiac-loaded TM patients, which
30 s process has led to strategies for treating chronic anemia in persistently infected patients and may
31                                              Chronic anemia in sickle cell disease results in cardiac
32 rticoids and other factors that occur during chronic anemia, inflammation, and other conditions of st
33 during any 12-month period, with SCD pain or chronic anemia interfering with daily activities, or wit
34 sion-dependent beta-thalassemia (TDT) mainly chronic anemia, iron overload and iron chelator toxicity
35 ted in patients with beta-thalassemia due to chronic anemia, iron overload, and iron chelation therap
36                                              Chronic anemia is a risk factor for CVD outcomes in pati
37 balamin (vitamin B12) is routinely tested in chronic anemia, its role in HHT has not been studied unt
38  in vivo and alleviated anemic symptoms in a chronic anemia mouse model by regulating erythroid gene
39          Moreover, in acquired and inherited chronic anemia mouse models, acetate supplementation inc
40 binant epoetin therapy and correction of the chronic anemia of renal failure have greatly reduced the
41 bsent in WT mice with experimentally induced chronic anemia of similar degree and duration.
42 embolism; (2) do not routinely transfuse for chronic anemia or uncomplicated pain crises in patients
43 dence indicates that retinal degeneration in chronic anemia patients treated by deferoxamine is cause
44 uter retinal degeneration in iron-overloaded chronic anemia patients who are treated with deferoxamin
45 nal iron absorption can be a complication of chronic anemias such as beta-thalassemia.
46 ystic fibrosis disease is characterized by a chronic anemia that is inadequately compensated by the c
47             The affected individuals present chronic anemia that varies in severity.
48 rected toward addressing the contribution of chronic anemia to poor outcomes in SCD.
49 he hypoxic response and not other effects of chronic anemia, we compared expression variation in peri
50    TNFalphaKO injected with HKBA displayed a chronic anemia, with elevated proinflammatory IL12p40 an